June 27, 2024
Amer Zeidan, MBBS
Associate Professor of Internal Medicine (Hematology); Chief, Hematologic Malignancies; Director, Early Therapeutics Research, Hematology; Leader, Clinical Research Team for Leukemias and Myeloid Malignancies, Yale Cancer Center; Chair, Protocol Review Committee (PRC) I, Yale Cancer Center; Assistant Medical Director, Clinical Trials Office (CTO), Yale Cancer Center; Director, Hematology Research Seminar Series, Hematology; Member, Executive Committee, Yale Cancer Center; Member, Clinical Trials Advisory Committee (CTAC), Yale Cancer Center
Biography
Research & Publications
Patient Care
News
Locations
News
- Source: Oncology Nursing News
- June 07, 2024
New Treatment Approved for Certain Patients Living With Myelodysplastic Syndromes
- June 07, 2024
Yale Cancer Center Researchers and Trainees Present at ASCO
- June 06, 2024Source: WTNH News 8
Connecticut Families: Brookfield dad gets bone marrow transplant from professional lacrosse player
- April 02, 2024
YCC Publications 2024
- March 07, 2024
Amer Zeidan, MBBS, MHS, appointed inaugural Chief of the Division of Hematologic Malignancies
- January 19, 2024
Novel Treatments for Myelodysplastic Syndromes
- December 04, 2023
Phase 3 Results Offer Hope for Patients With Myelodysplastic Syndromes